Schmidt opens dialogue with health sector stakeholders
This article was originally published in Clinica
Executive Summary
Leading representatives from the medical device and pharmaceutical industries, health insurance funds, patient and doctors' associations and hospitals have been invited by German health minister Ulla Schmidt to take part in a round-table meeting on May 7 in Berlin. The move, announced last weekend, is designed to provide a constructive dialogue, between the ministry of health and the 18 delegates, about the future of the German health service.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.